StockGuru.com Announces Profile Coverage of Lotus Pharmaceuticals


DALLAS, March 20, 2007 (PRIME NEWSWIRE) -- John Pentony, Publisher of StockGuru.com, announced today that the web site has initiated Profile Coverage of Lotus Pharmaceuticals, Inc. (OTCBB:LTUS). Lotus Pharmaceuticals is an emerging Chinese leader in offering medicines to ensure well-being, cure disease and improve quality of life. The company's goal is to discover, develop and successfully market innovative products to help people globally, to help patients manage afflictions and to enhance the quality of life. Lotus continues to discover, develop and successfully market innovative products to help people globally, to help patients manage afflictions and to enhance the quality of life. Lotus has a unique positioning amongst major pharmaceutical companies in China, as it resides in a small class of leadership in both patented and generic pharmaceuticals.

To view the StockGuru.com Profile for Lotus Pharmaceuticals, Inc., please visit:

http://www.stockguru.com/profiles/ltus

About StockGuru.com

StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visit:

http://www.stockguru.com/stocks.htm

To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031 or email publisher@stockguru.com. Our services include our Morning, Midday, and After The Bell news releases. Additionally, we profile publicly traded companies on our web site, we do interviews with CEOs or other key executives on our web site, and we have our financial writers cover our companies.

Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words `"estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Disclosure: Pentony Enterprises LLC was compensated $10,000 directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site are suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.



            

Contact Data